D. Back

Type de document

Articles (7) Recensions (4)

Co-auteur

C. Marzolini

S. Khoo

F. Marra

S. Gibbons

D. Burger

A. Boyle

M. Siccardi

M. Battegay

R. Weber

L. Waters

P. Vernazza

M. Stoeckle

F. Stader

A. J. Sommerville

E. J. Smolders

A. Pozniak

D.R. Kuritzkes

D. Hodge

C. Hodge

H.H. Hirsch

H. Furrer

C. Flexner

L. Elzi

O. El-Sherif

K. Davidson

M. Cavassini

A. Calmy

M. Boffito

E. Bernasconi

Date

Source

Serveur académique Lausannois (7)

Mot-clé

Human beings (7) Patients (6) Patients (6) Treatment (5) Drugs (5) Drug interactions (5) Use (4) thérapie (3) risque (3) pharmacocinétique (3) Therapeutics (3) Risk (3) Pharmacokinetics (3) Manufacturers' agents (3) Commission merchants (3) Older people (3) Pharmacokinetics (3) gestion (2) infection (2) effet (2) dosage (2) maladie (2) adulte (2) Methods (2) Comorbidity (2) Pneumonia (2) Management (2) Infection (2) Experience (2) Drug utilization (2)

Documents écrit par D. Back (7) | parle de D. Back (2)

Prescribing Nirmatrelvir-Ritonavir: How to Recognize and Manage Drug-Drug Interactions

C. Marzolini et al.

Recommendations for Dosing of Repurposed COVID-19 Medications in Patients with Renal and Hepatic Impairment

F. Marra et al.

COVID-19 treatment in patients with comorbidities: Awareness of drug-drug interactions

D. Back et al.

The challenge of HIV treatment in an era of polypharmacy

D. Back et al.

Drug interactions: a review of the unseen danger of experimental COVID-19 therapies

D. Hodge et al. (2020)

Stopping lopinavir/ritonavir in COVID-19 patients: duration of the drug interacting effect

F. Stader et al. (2020)

Ageing with HIV: medication use and risk for potential drug-drug interactions.

C. Marzolini et al. (2011)